Related Post

• Zinc Finger Protein Designed to Target 2-Long Terminal Repeat Junctions Interferes with Human Immunodeficiency Virus Integration - May 13th, 2012
• A Shield Against Chemotherapy - May 13th, 2012
• Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome - May 13th, 2012
• A paradigm shift in the delivery of services for diagnosis of inherited retinal disease - May 13th, 2012
• Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma - May 13th, 2012
• HIV Gene Therapy Safe Over Time (CME/CE) - May 6th, 2012
• Nanovector delivery of siRNA for cancer therapy - May 6th, 2012
• Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model - May 6th, 2012
• Interferon-? lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-? gene transfer to human tumor cells - May 6th, 2012
• MicroRNA silencing improves the tumor specificity of adenoviral transgene expression - May 6th, 2012
• Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC - May 6th, 2012
• Gene Hunt Is On for Mental Disabilities in Children - May 6th, 2012
• Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning - May 6th, 2012
• MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy - May 6th, 2012
• Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency - May 6th, 2012
• Study: Gene Therapy for HIV Safe, But Effectiveness Still Unclear - May 6th, 2012
• April 2012 Advances: Additional Resources - May 6th, 2012
• Scientists find 10 subsets of breast cancer - April 29th, 2012
• Synthetic Biologics Appoints Michael Kaleko, M.D., Ph.D., as Scientific Director - April 29th, 2012
• Genetic test could pave the way for breast cancer 'magic bullets' - April 29th, 2012
• Researchers discover two new genetic loci for obesity - April 29th, 2012
• 'Genetic Fix' From AVI Biopharma Builds Key Muscle Function Protein - April 29th, 2012
• Genetic testing for drug intolerance - April 29th, 2012
• Brooklyn godsend for teen with rare genetic disorder - April 29th, 2012
• Genetic Technologies' Subsidiary Update - April 29th, 2012
• Will we ever correct diseases before birth? | Not Exactly Rocket Science - April 29th, 2012
• Amsterdam Molecular Therapeutics Receives Further Opinion on Glybera® Marketing Authorisation Application - April 29th, 2012
• Gene therapy helps woman to write - April 29th, 2012
• Greenwich gala celebrates cancer therapy breakthrough - April 29th, 2012
• Gene therapy group looks to new frontiers in fight against cancer - April 29th, 2012
• Video: Gene therapy reverses Parkinson's symptoms: study - April 29th, 2012
• New York Mesothelioma Lawyer Applauds Advances in Gene Therapy Cited in New Book - April 29th, 2012
• Gene Therapy Restores Sight to Three Patients - April 29th, 2012
• Global Gene Therapy Industry - April 29th, 2012
• Research and Markets: Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders - April 29th, 2012
• Epirubicin potentiates recombinant adeno?associated virus type 2/5–mediated TRAIL expression in fibroblast?like synoviocytes and augments the antiarthritic effects of rAAV2/5?TRAIL - April 29th, 2012
• CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results - April 29th, 2012
• Prospects for gene transfer for clinical heart failure - April 29th, 2012
• Gene therapy for ventricular tachyarrhythmias - April 29th, 2012
• Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection - April 29th, 2012